Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 174   

Articles published

GSK 1,415.50 +3.50 (0.25%)
price chart
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Given the widespread nature of this problem, Western authorities have taken a keen interest in the activities of their biopharmaceutical companies both abroad and at home.
Related articles »  
GlaxoSmithKline plc (ADR) Declares Quarterly Dividend of $0.61 (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) announced a quarterly dividend on Thursday, October 23rd, Analyst Ratings News reports.
Related articles »  
Analyst Update: Alcatel Lucent SA (ADR), AT&T Inc., and GlaxoSmithKline plc ...
Analysts are weighing in today on networking firm Alcatel Lucent SA (ADR) (NYSE:ALU), telecom issue AT&T Inc. (NYSE:T), and pharmaceutical power GlaxoSmithKline plc (ADR) (NYSE:GSK). Here's a quick look at today's brokerage notes on ALU, T, and ...
Why GlaxoSmithKline plc Should Lag The FTSE 100 This Year
Announced on 19 September, the Chinese court found that Glaxo's Chinese subsidiary had illegally �offered money or property to non-government personnel in order to obtain improper commercial gains, and been found guilty of bribing non-government ...
Analysts' Recent Ratings Updates for GlaxoSmithKline plc (GSK)  WKRB News
GlaxoSmithKline plc Receives "Underperform" Rating from Credit ...  Watch List News (press release)
Related articles »  
GlaxoSmithKline plc's "Neutral" Rating Reiterated at JPMorgan Chase & Co. (GSK)
Separately, analysts at Panmure Gordon cut their price target on shares of GlaxoSmithKline plc from GBX 1,600 ($25.75) to GBX 1,425 ($22.93) in a research note on Wednesday.
Searching For Value In A Plunging Market: GlaxoSmithKline plc & Ted Baker plc ...
The shares of Royal Mail Group (LSE: RMG) and Aviva (LSE: AV) outperformed those of more cyclical businesses on Wednesday, when volatility began to rise, yet they gave up their gains on Thursday.
GlaxoSmithKline plc Short Interest Down 42.0% in September (GSK)
GlaxoSmithKline plc logo Shares of GlaxoSmithKline plc (NYSE:GSK) were the target of a significant decrease in short interest in the month of September.
Related articles »  
5 Things You May Not Know About Pay At GlaxoSmithKline plc
GlaxoSmithKline Executive pay continues to rankle many shareholders. So I'm reading the remuneration reports of leading FTSE 100 companies to help you decide whether your investments are being run by herd of 'fat cats'.
Why GSK Has Been Immune To Ebola Gains
Some companies are also working on a vaccine for Ebola, of which NewLink and GSK are at an advanced stage. GSK has already started human trials in the US and UK and is manufacturing 10,000 doses of the vaccine, whose use is contingent on the ...
Ebola Vaccine Trials May Give Placebo To Those At Risk
Related articles »  
GlaxoSmithKline Plc (GSK) Earnings Report: Q3 2014 Conference Call Transcript
The following GlaxoSmithKline plc (GSK) conference call took place on October 22, 2014, 09:00 AM ET. This is a transcript of that earnings call: Company Participants.